ArticlePDF Available

A Multidisciplinary Model of Care for Childhood Cancer Survivors With Complex Medical Needs

Authors:

Abstract and Figures

Long-term survival for children with cancer is often achieved at a considerable cost in terms of medical and psychological sequelae. Although many survivors are well and require only routine follow-up and surveillance, a cohort of survivors require comprehensive management of complex, chronic medical issues by multiple subspecialists. For these survivors, care delivered within the context of an annual visit to a traditional hospital-based late effects clinic or by a primary care physician in the community is often not adequate. A specialized clinic was implemented at The Children's Hospital of Philadelphia that crosses disciplines and provides same-day, same-clinic access to oncology/survivorship, endocrinology, pulmonology, cardiology, nutrition, and psychology. This multidisciplinary approach supports clinical efficiency and fosters seamless patient-centered care both for patients with identified late effects and for those with the highest risk for problems because of intense treatment exposures. The model is described with a focus on clinic structure/process, clinical outcomes, and benefits to survivor, health care provider, and institution. The diverse roles for nursing within this model are highlighted.
Content may be subject to copyright.
http://jpo.sagepub.com
Journal of Pediatric Oncology Nursing
DOI: 10.1177/1043454207311741
2008; 25; 7 Journal of Pediatric Oncology Nursing
Claire A. Carlson, Wendy L. Hobbie, Melinda Brogna and Jill P. Ginsberg
A Multidisciplinary Model of Care for Childhood Cancer Survivors With Complex Medical Needs
http://jpo.sagepub.com/cgi/content/abstract/25/1/7
The online version of this article can be found at:
Published by:
http://www.sagepublications.com
On behalf of:
Association of Pediatric Hematology/Oncology Nurses (APHON)
can be found at:Journal of Pediatric Oncology Nursing Additional services and information for
http://jpo.sagepub.com/cgi/alerts Email Alerts:
http://jpo.sagepub.com/subscriptions Subscriptions:
http://www.sagepub.com/journalsReprints.navReprints:
http://www.sagepub.com/journalsPermissions.navPermissions:
http://jpo.sagepub.com/cgi/content/refs/25/1/7 Citations
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
Journal of Pediatric Oncology Nursing, Vol 25, No 1 (January), 2008: pp 7-13 7
A Multidisciplinary Model of Care for Childhood
Cancer Survivors With Complex Medical Needs
Claire A. Carlson, BSN, RN
Wendy L. Hobbie, MSN, RN, CRNP
Melinda Brogna, BSN, RN
Jill P. Ginsberg, MD
© 2008 by Association of Pediatric Hematology/Oncology Nurses
DOI: 10.1177/1043454207311741
Long-term survival for children with cancer is
often achieved at a considerable cost in terms of med-
ical and psychological sequelae. Although many sur-
vivors are well and require only routine follow-up
and surveillance, a cohort of survivors require com-
prehensive management of complex, chronic medical
issues by multiple subspecialists. For these survivors,
care delivered within the context of an annual visit to
a traditional hospital–based late effects clinic or by a
primary care physician in the community is often not
adequate. A specialized clinic was implemented at
The Children’s Hospital of Philadelphia that crosses
disciplines and provides same-day, same-clinic
access to oncology/survivorship, endocrinology, pul-
monology, cardiology, nutrition, and psychology. This
multidisciplinary approach supports clinical effi-
ciency and fosters seamless patient-centered care
both for patients with identified late effects and for
those with the highest risk for problems because of
intense treatment exposures. The model is described
with a focus on clinic structure/process, clinical out-
comes, and benefits to survivor, health care provider,
and institution. The diverse roles for nursing within
this model are highlighted.
Key words: childhood cancer, late effects, survivor-
ship, long-term follow-up, model of care
D
ue to advances in the diagnosis and treatment of
pediatric malignancies over the past 4 decades,
the number of long-term survivors of childhood can-
cer continues to grow. With the overall cure rate for
pediatric malignancies now approaching 80%, current
estimates indicate that there are more than 270 000
childhood cancer survivors in the United States and
that 1 in every 640 young adults is a survivor of a
pediatric malignancy (Hewitt, Weiner, & Simone,
2003; Meadows, 2006; Ries et al., 1999). Although
this number of survivors is remarkable, long-term
survival for children with cancer may be achieved at
a considerable cost in terms of medical and psycho-
logical sequelae. Recently published data using the
cohort from the Childhood Cancer Survivor Study
indicate that among 10 397 survivors, 62.3% have at
least 1 chronic health condition and 27.5% have a
condition that is considered severe or life-threatening.
Among survivors, the cumulative incidence of a chronic
Claire A. Carlson, BSN, RN is a research nurse with the Cancer
Survivorship Program at The Children’s Hospital of Philadelphia. She
coordinates the Multidisciplinary Cancer Survivorship Clinic. Wendy L.
Hobbie, MSN, CRNP, is the nurse coordinator for the Cancer Survivorship
Program at The Children’s Hospital of Philadelphia. Melinda Brogna,
BSN, RN, is a staff nurse in the Oncology Outpatient Clinic at The
Children’s Hospital of Philadelphia. She is the primary clinic nurse for the
Multidisciplinary Cancer Survivorship Clinic. Jill P. Ginsberg, MD, is an
attending physician in the Division of Oncology at The Children’s
Hospital of Philadelphia. She is associate director of the Cancer
Survivorship Program. Address for correspondence: Claire A. Carlson,
BSN, RN, Cancer Survivorship Program, The Children’s Hospital of
Philadelphia, 34th Street and Civic Center Blvd, Wood Building, Room
4310, Philadelphia, PA 19104; e-mail: carlsoncl@email.chop.edu.
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
Carlson et al
health condition reached 73.4% (95% confidence
interval, 69.0-77.9) 30 years after the cancer diagno-
sis, with a cumulative incidence of 42.4% (95% con-
fidence interval, 33.7-51.2) for severe, disabling, or
life-threatening conditions or death attributable to a
chronic condition (Oeffinger et al., 2006).
Specific challenges for survivors with multiple
chronic health conditions include appointments with
subspecialists on varying days of the week, missed
time from school and work for medical appointments,
and difficulty coordinating necessary follow-up visits
and diagnostic testing across multiple specialties and
ancillary providers. Survivors also face the monu-
mental task of facilitating seamless communication
between different providers involved in their care.
A variety of models are available for delivering
care to survivors, and the best model often varies
from patient to patient. Those patients with the most
complex treatment histories and at-risk treatment
exposures require a more specialized level of care,
often multidisciplinary, throughout their lives
(Friedman, Freyer, & Levitt, 2006; Wallace et al.,
2001). The multidisciplinary concept is not new and
is accepted among professionals in both survivorship
and other pediatric arenas as the ideal way to deliver
care to patients with complex, often chronic, health
care needs. However, translating a multidisciplinary
philosophy into clinic practice can be a challenge. In
current practice, the term multidisciplinary is not
always used to reference a specific model for clinical
care. Rather, the term often implies a close relation-
ship with an established network of pediatric and
adult subspecialists for referrals as needed; it does not
necessarily mean that specialists are integrated into
the clinic visit (Bhatia & Meadows, 2006; Hudson
et al., 2004; Oeffinger, 2003; Oeffinger & McCabe,
2006). Some programs in the United States and other
countries are using multidisciplinary clinics for sur-
vivorship care (Hinkle et al., 2004; Rigon, Lopes,
Latorre, & de Camargo, 2003; Skinner, Wallace &
Levitt, 2006; Taylor et al., 2004). A recent survey of
24 long-term follow-up programs in the United States
and Canada indicated that about 21% of those sur-
veyed included other subspecialists in their clinic
such as radiation oncology, endocrinology, cardiology,
and neurology (Aziz, Oeffinger, Brooks, & Turoff,
2006). The logistics of clinic operation and the level
of subspecialist involvement in clinical care in these
programs are not well described in the literature. A
Multidisciplinary Cancer Survivorship Clinic currently
in operation at The Children’s Hospital of Philadelphia
is described here with a focus on clinic structure, care
delivery, and benefits to survivor, health care provider,
and institution.
Clinic Structure and Process
A multidisciplinary clinic model was piloted at
The Children’s Hospital of Philadelphia beginning in
January 2006. The primary goal of the program was
to provide a specialized clinic within a cancer sur-
vivorship program that crosses disciplines and pro-
vides same-day, same-clinic access to oncology/
survivorship, endocrinology, pulmonology, cardiology,
nutrition, and psychology. Figure 1 illustrates the
overall multidisciplinary model.
The clinic is funded by the Department of
Pediatrics Chair’s Initiatives as part of a hospital-wide
effort to promote the development of new and innova-
tive ways to provide care that places the patient at the
center of every hospital experience. Funding provides
salary support for each of the specialists involved in
the clinic, for the nurse coordinator, and for adminis-
trative tasks associated with clinic operations.
The Multidisciplinary Cancer Survivorship Clinic
is held once per month. All patient visits are held in
the oncology clinic. Survivorship, psychology, and
nutrition providers see patients throughout the day,
and the other specialists hold half-day clinics.
Appropriate patients are identified for this clinic from
multiple sources including those patients known to
the survivorship team from previous visits, patients
known to one of the participating subspecialists, and
from new referrals within the Division of Oncology
and other divisions throughout the hospital.
Patient appointments are coordinated centrally by
a nurse who, in collaboration with the oncology prac-
titioner, reviews the patient’s history and treatment
exposures, determines the specialists’ visits that are
needed, and schedules the appropriate risk-based
screening tests per the Children’s Oncology Group
guidelines (Landier et al., 2004). Specialist visits are
arranged both for those patients with known late
effects and for those patients at the highest risk for
late sequelae because of specific treatment exposures.
For example, a patient who received total body irradia-
tion or whole lung irradiation would get a pulmonary
screening visit; likewise, a patient who received a
large dose of anthracyclines (>300 mg/m
2
) would
8 Journal of Pediatric Oncology Nursing 25(1); 2008
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
receive a cardiology screening visit. All patients are
scheduled for nutrition and psychology visits unless
the parent or patient does not want to use these serv-
ices. Oncology, endocrinology, cardiology, and pul-
monology each bill separately, and reimbursement
for provider visits and ancillary services (labs,
echocardiograms, pulmonary function tests) has been
collected at a rate equivalent to the overall hospital
collection rate. Nutrition and psychology are not bill-
able services in the current clinic structure.
On the morning of the clinic, the multidisciplinary
team reviews the patient’s care plan at a preclinic
conference. Providers are assigned to a room, and
patients move from provider to provider. Each
patient has a “shadow chart,” which contains a sum-
mary of his or her cancer history and treatment expo-
sures, pertinent testing results and correspondence,
and encounter forms for documenting each special-
ist’s assessment and plan. The shadow chart follows
the patient throughout the day so that providers are
aware of what has transpired in previous visits. This
chart helps with continuity of care and facilitates the
delivery of a consistent message to the survivor
across disciplines.
During the course of the clinic visit, an active
problem list for each patient is generated, interven-
tions are recommended, and a plan for follow-up is
developed. The plan of care for each patient is dis-
cussed in detail in the multidisciplinary postclinic
conference. This provides an opportunity for all of
the subspecialists to review their findings and recom-
mendations and allows for continuity of care across
disciplines. Finally, a summary letter, which blends
the patient’s oncology history with the visit notes
from all of the subspecialists who encountered the
patient, is developed. Clinic providers dictate their
exam findings, impression, and plan according to
their normal practice, and then the components are
incorporated into a comprehensive letter that includes
the survivor’s cancer history and treatment exposures.
The letter is shared with all of the providers involved
in the survivor’s care, the primary care physician, and
the patient. Any required interval follow-up testing is
coordinated by the survivorship team.
Clinic Outcomes
Utilization
During the first 18 months of clinic operation
(January 2006 to June 2007), 130 patients used the
Multidisciplinary Cancer Survivorship Clinic, account-
ing for 556 specialty encounters and 403 ancillary
encounters. The largest proportions of patients using this
level of service were survivors of brain tumors (25%),
neuroblastoma (24%), and acute lymphocytic leukemia
(22%) (Figure 2). Twenty-five percent of patients were
Model of Care for Childhood Cancer Survivors
Journal of Pediatric Oncology Nursing 25(1); 2008
9
Late Effects Visit
Treatment History
Physical Exam
Risk-Based Screening
& Counseling
Survivor
One Appointment
One Location
Same Day Service
Subspecialist(s) Visits
Oncology (1 MD, 1 APN)
Endocrinology (1 MD, 1 APN)
Pulmonology (1 MD)
Psychology (1 PhD)
Cardiology (1 MD)
Nutrition (1 Registered Dietician)
Anticipated Ben efits
Patient
*Improved access to multiple subspecialists
*Less time lost from school and work
*Improved communication between late effects team and subspecialists
Healthcare Provider
*Opportunity for collaborative clinical care
*Seamless provider communication and continuity of care
*Enhanced efficiency and clinical effectiveness
*Rich environment for collaborative research
*Environment to train health care providers regarding late effects
Institution
*Expansion of service line
*Increased patient volume/n ew referrals
*Improved patient (customer) satisfaction
Figure 1. Multidisciplinary Model for Care of Survivors With Complex Health Care Needs
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
Carlson et al
treated for relapse with intensive chemotherapy, and
43% had received stem cell transplant.
Referrals Without Follow-up
As part of the outcome metrics for the clinic, we
systematically tracked patients over the first 18
months of clinic operation who were referred in the
past to one of the participating subspecialists but did
not follow through and were subsequently captured
within the multidisciplinary clinic visit. Anecdotally,
we had found that it was not unusual to refer a patient
to a subspecialist and then find out at next year’s late
effects visit that this patient never saw the physician
for a consult. Twenty-six of the 130 patients (20%)
who used the multidisciplinary clinic were identified
as past failure to follow up on a referral to endocrinol-
ogy, pulmonology, or cardiology. The availability of a
multidisciplinary clinic may help to reduce the
instances of sporadic patient follow-up and, in turn,
will improve the clinical care for these survivors.
Identification of New Problems
Identification of new medical problems was also an
advantage of the multidisciplinary approach. An inte-
grated team of subspecialists may allow for earlier
diagnosis of certain late effects or, at minimum, earlier
identification of more subtle changes in diagnostic
testing or physical manifestations of changes in organ
function. New problems identified during these clinic
visits included growth hormone deficiency/resistance,
hypothyroidism, hypogonadism, advanced bone age,
restrictive lung disease, left ventricular dysfunction,
and prolonged QTc interval. Table 1 summarizes the
number of patients within each subspecialty who had
a new medical problem identified at their clinic visit.
Although it is true that some of these issues would
have likely been identified within the context of the
oncology visit, the advantage here is having immedi-
ate access to the clinical expert to plan for further eval-
uation and intervention.
Patient and Family Satisfaction
A patient satisfaction survey was sent out after
each clinic to elicit feedback about the multidiscipli-
nary experience. Surveys were anonymous to ensure
that families would feel comfortable providing us
with their thoughts about what worked and where
improvements were needed. Benefits identified by
patients and families included a reduction in the time
needed to schedule multiple medical appointments
and fewer missed days from work and school.
Patients who used the clinic felt that their treatment
plans were now more coordinated across specialties;
86% indicated that new issues about their child’s
health were identified during the multidisciplinary
visit, and 100% would use the clinic again.
Nursing Roles
The role of nursing in the care of childhood cancer
survivors is well established in the literature (Fochtman,
1995; Gibson & Soanes, 2001; Harvey, Hobbie, Shaw,
& Bottomley, 1999; Hobbie & Hollen, 1993; Kolb
Smith, 2002; Ruccione & Fergusson, 1984). In the
early evolution of long-term follow-up clinics, the
advanced practice nurse was central to clinic develop-
ment, clinical care, patient education, and research.
10 Journal of Pediatric Oncology Nursing 25(1); 2008
22%
9%
2%
6%
25%
24%
2%
7%
3%
ALL
AML/JCML
Mixed Lineage
Leukemia
Anemia/
Other Heme
Brain Tumor
Neuroblastoma
Retinoblastoma
Lymphomas
Ewing’s
Sarcoma
Figure 2. Patients by Diagnosis.
NOTE: ALL = acute lymphocytic leukemia. AML = acute myeloge-
nous leukemia. JCML = juvenile chronic myelogenous leukemia
Table 1. Patients With New Problems Identified
No. of Patients With a New
Identifying Medical Problem Identified At
Subspecialist Multidisciplinary Clinic Visit
Survivorship 31
Endocrinology 40
Pulmonary 23
Cardiology 16
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
Hobbie and Hollen (1993) described a model for the
advanced practice nurse role in late effects care that
not only encompassed specialty care provider, educa-
tor, and researcher but also included program manager
and consultant. These roles have continued through
nursing’s rich history in providing care to long-term
survivors and are evident in this multidisciplinary
approach to survivorship care. Roles for nursing in the
multidisciplinary model are not limited to the
advanced practice nurse; there are also opportunities
for registered nurses with varying levels of education
and experience. Four major nursing roles can be
defined in the multidisciplinary clinic, and each is
essential to the clinic’s overall success and to provid-
ing the ideal patient experience (Table 2).
Discussion
For patients with multiple late effects and for
whom multiple subspecialists are required to manage
their health care needs, an annual visit to a local
practitioner or to a traditional late effects clinic is not
likely to be sufficient. Proper follow-up care for this
cohort of survivors requires the coordination of mul-
tiple outpatient visits with one or more subspecialists.
This level of care necessitates additional trips to the
hospital and often places a significant strain on both
patient and parent, who may have to negotiate com-
plex and disjointed hospital infrastructure to schedule
appointments and appropriate screening tests. These
survivors may also often miss multiple days from work
or school to accommodate medical appointments
throughout the year. Regardless of parental or patient
expertise in navigating the health care system, the
current structure of survivorship care within our insti-
tution fell short of providing an ideal patient experi-
ence for some of our more complex patients. As a
result, necessary follow-up with subspecialists was
sporadic or, in some cases, missed entirely.
The breadth and consistency of specialist involve-
ment and the comprehensive level of service provided
by the multidisciplinary model at The Children’s
Hospital of Philadelphia described here have shown
Model of Care for Childhood Cancer Survivors
Journal of Pediatric Oncology Nursing 25(1); 2008
11
Table 2. Nursing Roles in Multidisciplinary Approach to Survivorship Care
Nurse Coordinator Outpatient Clinic Nurse Advanced Practice Nurse Research Nurse
Contributes to overall business
plan for clinic
Oversees administrative tasks
Communicates with ancillary
staff providing service to the
clinic
Prepares patient summary with
pertinent cancer history and
treatment exposures
Schedules risk-based screening
and subspecialist visits for
patient
Educates patients and families
regarding potential late
effects and the importance of
follow-up care
Acts as resource for
information on insurance
and referrals
Serves as primary point of
contact for patients, families,
and members of the care
team at clinic visit
Coordinates follow-up
appointments and testing
according to multidisciplinary
plan of care
Maintains patient flow
Provides direction for patients
and providers during clinic
visit; keeps patient and team
on track
Acts as core clinical liaison
between patients and health
care team
Answers questions and
educates patients and
families
Educates nursing staff
regarding late effects
Brings nursing perspective to
multidisciplinary clinic
rounds
Acts as hands-on care provider
with clinical expertise on
care of childhood cancer
survivors
Coordinates patient plan of
care in conjunction with
other subspecialists
Serves as clinical “point
person” for patients and
families
Participates in
multidisciplinary clinic
rounds
Provides postclinic follow-up
and communication with
patients and families (testing
results, plan of care, referral
to other specialists as
needed)
Collaborates with team to
generate research
questions/ideas and
participates in ongoing
research studies
Maintains regulatory
documents for late effects
studies
Identifies and recruits eligible
patients to late effects
research studies
Acts as data manager for open
studies
Collaborates with team to
generate research questions
and ideas
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
Carlson et al
promise in the ability to improve care for long-term
survivors with complex medical needs. By providing
same-day, same-clinic access to multiple subspecial-
ists with survivorship expertise, the program supports
clinical efficiency and fosters seamless patient-
centered care both for patients with identified late
effects and for those with the highest risk for prob-
lems because of intense treatment exposures.
The multidisciplinary clinic environment also pro-
vides fertile ground for collaborative research and
offers a unique way to identify research questions,
which can affect how survivors with chronic and
complex long-term medical needs are monitored and
cared for as they move through their life span. Pre-
and postclinic conferences offer an ideal setting in
which to pinpoint potential trends in patient outcomes
and to classify and describe late effects in specific
patient populations. There is also the opportunity to
collect pertinent clinical data across disciplines and to
catalog that information in an organized manner for
future research queries. In some cases, at-risk patients
are seen before any overt signs of disease develop.
This fosters the type of prospective longitudinal stud-
ies described by Bhatia and Meadows (2006), which
could allow clinicians to begin to understand the
pathogenesis of certain outcomes of interest, laying
the groundwork for potential intervention studies in
the future. The multidisciplinary clinic also provides
an ideal setting in which to educate and train health
care professionals in the late effects of cancer therapy
and to potentially cultivate early interest of residents
or fellows in other specialties in the issues facing can-
cer survivors.
Benefits of the model can be found at multiple lev-
els. At the patient level, survivors are able to minimize
the amount of time they need to give to medical
follow-up and maximize the amount of clinical care
that they can obtain in a single clinic visit. For the
health care provider, it is a unique opportunity to pro-
vide collaborative care for a complex patient popula-
tion and to conduct research studies with a population
of survivors at the greatest risk for long-term prob-
lems. This is particularly true for nursing and high-
lights how the profession continues to play a vital role
in survivorship care. From an institutional perspective,
the clinic has shown the ability to provide an ideal
patient and family experience. It is our hope that the
multidisciplinary approach will demonstrate utility
beyond survivorship and will provide a model of care
for children and young adults with other chronic and
complex health care needs. Future areas of research
include more formalized assessment of the impact of
a multidisciplinary model of care on health outcomes,
utilization of health care services, and the potential
cost savings of providing care in this manner.
Acknowledgments
We would like to thank Alan Cohen, MD, and the
Department of Pediatrics, for their support of this
clinic. We would also like to thank our subspecialist
collaborators: Thomas Moshang, MD, Sherry Tsai,
CRNP, and Diana Kong, CRNP, Division of
Endocrinology; Samuel Goldfarb, MD, Division of
Pulmonary Medicine; Elizabeth Goldmuntz, MD,
Beth Kaufman, MD, and Maryanne Chrisant, MD,
Division of Cardiology; Mary T. Rourke, PhD,
Psychology; Nancy Sacks, RD, and Sue Ogle, CRNP,
Nurse Manager, Outpatient Oncology Clinic.
References
Aziz, N. M., Oeffinger, K. C., Brooks, S., & Turoff, A. J. (2006).
Comprehensive long-term follow-up programs for pediatric
cancer survivors. Cancer, 107, 841-848.
Bhatia, S., & Meadows, A. T. (2006). Long-term follow-up of
childhood cancer survivors: Future directions for clinical care
and research. Pediatric Blood & Cancer, 46, 143-148.
Fochtman, D. (1995). Follow-up care for survivors of childhood
cancer. Nurse Practitioner Forum, 6, 194-200.
Friedman, D. L., Freyer, D. R., & Levitt, G. A. (2006). Models of
care for survivors of childhood cancer. Pediatric Blood &
Cancer, 46, 159-168.
Gibson, F., & Soanes, L. (2001). Long-term follow-up following
childhood cancer: Maximizing the contribution from nursing.
European Journal of Cancer, 37, 1859-66.
Harvey, J., Hobbie, W. L., Shaw, S., & Bottomley, S. (1999).
Providing quality care in childhood cancer survivorship:
Learning from the past, looking to the future. Journal of
Pediatric Oncology Nursing,
16, 117-125.
Hewitt, M., Weiner, S. L., & Simone, J. V. (2003). Childhood
cancer survivorship: Improving care and quality of life.
Washington, DC: National Academy Press.
Hinkle, A. S., Proukou, C., French, C. A., Kozlowski, A. M.,
Constine, L. S., Lipsitz, S. R., et al. (2004). A clinic-based,
comprehensive care model for studying late effects in long-term
survivors of pediatric illnesses. Pediatrics, 113, 1141-1145.
Hobbie, W. L., & Hollen, P. J. (1993). Pediatric nurse practition-
ers specializing with survivors of childhood cancer. Journal of
Pediatric Health Care, 7, 24-30.
Hudson, M. M., Hester, A., Sweeney, T., Kippenbrock, S.,
Majcina, R., Vear, S., et al. (2004). A model of care for child-
hood cancer survivors that facilitates research. Journal of
Pediatric Oncology Nursing, 21, 170-174.
12
Journal of Pediatric Oncology Nursing 25(1); 2008
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
Kolb Smith, P. C. (2002). The role of the primary care advanced
practice nurse in evaluating and monitoring childhood cancer
survivors for a second malignant neoplasm. Journal of
Pediatric Oncology Nursing,
19, 84-96.
Landier, W., Bhatia, S., Eshelman, D. A., Forte, K. J., Sweeney, T.,
Hester, A. L., et al. (2004). Development of risk-based guide-
lines for pediatric cancer survivors: The Children’s Oncology
Group long-term follow-up guidelines from the Children’s
Oncology Group late effects committee and nursing discipline.
Journal of Clinical Oncology, 22, 4979-4990.
Meadows, A. T. (2006). Pediatric cancer survivorship: research and
clinical care. Journal of Clinical Oncology, 24, 5160-5165.
Oeffinger, K. C. (2003). Longitudinal risk-based health care for
adult survivors of childhood cancer. Current Problems in
Cancer, 27, 143-167.
Oeffinger, K. C., & McCabe, M. S. (2006). Models for delivering
survivorship care. Journal of Clinical Oncology, 24, 5117-5124.
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T.,
Hudson, M. M., Meadows, A. T., et al, for the Childhood
Cancer Survivor Study. (2006). Chronic health conditions in
adult survivors of childhood cancer. New England Journal of
Medicine, 355, 1572-1582.
Ries, L. A. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T.,
Young, J.L., et al. (1999). Cancer incidence and survival
among children and adolescents: United States SEER pro-
gram 1975-1995, National Cancer Institute, SEER Program
(NIH Publication No. 99-4649). Bethesda, MD: National
Institutes of Health.
Rigon, H., Lopes, L. F., Latorre, M. R., & de Camargo, B. (2003).
The GEPETTO program for surveillance of long-term survivors
of childhood cancer: preliminary report from a single institution
in Brazil. Medical and Pediatric Oncology, 40, 405-406.
Ruccione, K., & Fergusson, J. (1984). Late effects of childhood
cancer and its treatment. Oncology Nursing Forum, 11, 55-64.
Skinner, R., Wallace, W. H., & Levitt, G. A. (2006). Long-term
follow-up of people who have survived cancer during child-
hood. The Lancet Oncology, 7, 489-498.
Taylor, A., Hawkins, M., Griffiths, A., Davies, H., Douglas, C.,
Jenney, M., et al. (2004). Long-term follow-up pf survivors of
childhood cancer in the UK. Pediatric Blood & Cancer, 42,
161-168.
Wallace, W., Blacklay, A., Eiser, C., Davies, H., Hawkins, M.,
Levitt, G.A., et al. (2001). Developing strategies for long term
follow up of survivors of childhood cancer. BMJ, 323, 271-274.
Model of Care for Childhood Cancer Survivors
Journal of Pediatric Oncology Nursing 25(1); 2008
13
at UNIV PENNSYLVANIA LIBRARY on November 6, 2008 http://jpo.sagepub.comDownloaded from
... There were two randomized controlled trials [26,27] and six cohort studies that included a comparator group [28][29][30][31][32][33]. The remaining studies included 12 descriptive observational studies that followed a population of survivors over time [34][35][36][37][38][39][40][41][42][43][44][45], four retrospective cohort studies [46][47][48][49], eight cross-sectional survey studies [35,[50][51][52][53][54][55][56], five qualitative interview studies [57][58][59][60][61], and one used mixed methods with both survey and interview data [62]. Overall, as studies were mostly observational rather than experimental in nature, 58% were graded Level IV evidence [24] (Supplementary file). ...
... Ten studies described models of paediatric LTFU care, provided by the treating cancer centre with a focus on surveillance for cancer recurrence [37,40,43,46,48,52,55,57,58,61]. Seven studies described a multidisciplinary model of care, provided through referral to a dedicated survivorship clinic [29,39,41,42,45,47,49]. These multidisciplinary models of care included coordinated access to in-person review/surveillance by multiple disciplines and subspecialties. ...
... No differences in wait times [28] Multidisciplinary coordinated model ↓Wait times [45] Content courtesy of Springer Nature, terms of use apply. Rights reserved. ...
Article
Full-text available
Purpose This study aimed to systematically map elements of care and respective outcomes described in the literature for different models of post-treatment care for survivors of childhood cancer. Methods MEDLINE, CINAHL, and Embase were searched with combinations of free text terms, synonyms, and MeSH terms using Boolean operators and are current to January 2024. We included studies that described post-treatment cancer survivorship models of care and reported patient or service level elements of care or outcomes, which we mapped to the Quality of Cancer Survivorship Care Framework domains. Results Thirty-eight studies with diverse designs were included representing 6101 childhood cancer survivors (or their parent/caregiver) and 14 healthcare professionals. A diverse range of models of care were reported, including paediatric oncologist-led long-term follow-up, multi-disciplinary survivorship clinics, shared-care, and primary care-led follow-up. Elements of care at the individual level most commonly included surveillance for cancer recurrence as well as assessment of physical and psychological effects. At the service level, satisfaction with care was frequently reported but few studies reported how treatment-related-late effects were managed. The evidence does not support one model of care over another. Conclusions Gaps in evidence exist regarding distal outcomes such as costs, health care utilization, and mortality, as well as understanding outcomes of managing chronic disease and physical or psychological effects. The findings synthesized in this review provide a valuable reference point for future service planning and evaluation. Implications for Cancer Survivors Decades of research highlight the importance of survivorship care for childhood cancer survivors who are at risk of serious treatment-related late effects. This review emphasizes there is no single, ‘one-size fits all’ approach for delivering such care to this vulnerable population.
... There was a high level of user satisfaction across included studies (Carlson, Hobbie, Brogna, & Ginsberg, 2008;Coburn et al., 2020;Hardy et al., 2019;Hughes et al., 1991;Jackson et al., 1992;Morad et al., 2007;Naar-King et al., 2002Schwartz et al., 2011;Sutton et al., 2008;Williams et al., 1995). Significant between-group differences in satisfaction favouring intervention were demonstrated in analytic studies of comprehensive, screening and multidisciplinary interventions (Bickman, 1996;Grupp-Phelan et al., 2012;Schurman & Friesen, 2010;Simon et al., 2017;Stein & Jessop, 1984Tiberg et al., 2014Tiberg et al., , 2016. ...
... Significant longitudinal improvements in satisfaction were demonstrated (Cohen et al., 2010;Hardy et al., 2019) as well as non-significant longitudinal improvement (Grossman et al., 1999;Logan et al., 2012;Morad et al., 2007). Qualitative analyses and surveys of user experience revealed satisfaction with family-centredness of care (Cohen et al., 2010), information access (Hughes et al., 1991;Sutton et al., 2008;van Karnebeek et al., 2014;Williams et al., 1995), coordination of care (Carlson et al., 2008;Coburn et al., 2020;Cohen et al., 2010; and accessibility of medical specialists (Coburn et al., 2020;van Karnebeek et al., 2014) in coordinated or multidisciplinary clinics. Also see Appendix S5. ...
Article
Full-text available
Background Children and young people (CYP) with comorbid physical and/or mental health conditions often struggle to receive a timely diagnosis, access specialist mental health care, and more likely to report unmet healthcare needs. Integrated healthcare is an increasingly explored model to support timely access, quality of care and better outcomes for CYP with comorbid conditions. Yet, studies evaluating the effectiveness of integrated care for paediatric populations are scarce. Aim and Methods This systematic review synthesises and evaluates the evidence for effectiveness and cost‐effectiveness of integrated care for CYP in secondary and tertiary healthcare settings. Studies were identified through systematic searches of electronic databases: Medline, Embase, PsychINFO, Child Development and Adolescent Studies, ERIC, ASSIA and British Education Index. Findings A total of 77 papers describing 67 unique studies met inclusion criteria. The findings suggest that integrated care models, particularly system of care and care coordination, improve access and user experience of care. The results on improving clinical outcomes and acute resource utilisation are mixed, largely due to the heterogeneity of studied interventions and outcome measures used. No definitive conclusion can be drawn on cost‐effectiveness since studies focused mainly on costs of service delivery. The majority of studies were rated as weak by the quality appraisal tool used. Conclusions The evidence of on clinical effectiveness of integrated healthcare models for paediatric populations is limited and of moderate quality. Available evidence is tentatively encouraging, particularly in regard to access and user experience of care. Given the lack of specificity by medical groups, however, the precise model of integration should be undertaken on a best‐practice basis taking the specific parameters and contexts of the health and care environment into account. Agreed practical definitions of integrated care and associated key terms, and cost‐effectiveness evaluations are a priority for future research.
Article
Access to and understanding one's medical history is crucial to maintaining long-term care. As adolescents and young adults childhood cancer survivors age, they must transition and transfer their health care from their pediatric to an adult care institution. In this study, we provide empirical evidence reporting on the after-cancer treatment experiences of childhood cancer survivors through their transition. We report findings from 24 semi-structured interviews with adolescent and young adult cancer survivors participating in a childhood cancer survivorship program that prepares them for adult care. Our findings reveal three parts of their after-cancer treatment experience: the assumption of responsibility for their complex care needs and medical information and the overall transfer and maintenance of the continuity of their care to an adult clinician. Our findings suggest that survivors may play an essential yet unrecognized role in the patient hand-off. Thus, we introduce patient-mediate handoffs and suggest design opportunities.
Article
Background Multidisciplinary clinics are expected to improve patient care by enhancing efficiency for both patients and care providers. We hypothesized that while these clinics are an efficient use of time for patients, they can limit a surgeon’s productivity. Methods A retrospective review was performed for patients evaluated in a Multidisciplinary Endocrine Tumor Clinic (MDETC) and Multidisciplinary Thyroid Cancer Clinic (MDTCC) from 2018 to 2021. Time from evaluation to surgery and prevalence of surgery were evaluated. Patients were compared to those evaluated in a surgeon-only endocrine surgery clinic (ESC) from 2017 to 2021. Chi-square and t-tests were used to test significance. Results Patients referred to the ESC underwent surgery more often than those referred to either multidisciplinary clinic (ESC 79.5%, MDETC 24.6%, MDTCC 7%; P < .001) but had a significantly longer delay between appointment and operation (ESC 19.9 days, MDETC 3.3 days, MDTCC 16.4 days; P < .001). Patients had a longer wait from referral to appointment for the MDCs (ESC 22.6 days, MDETC: 44.5, MDTCC 33; P < .05). There was no significant difference in miles traveled by patients to any clinic. Conclusion Multidisciplinary clinics can provide fewer appointments and faster time to surgery for patients but may lead to longer wait time from referral to appointment and fewer overall surgeries than endocrine surgeon-only clinics.
Article
Objective To describe the burden of adverse kidney and cardiovascular outcomes in patients evaluated by pediatric nephrology in a multidisciplinary survivorship clinic. Study design Retrospective chart review of all patients followed by nephrology in our multidisciplinary survivorship clinic from 8/2013-6/2021. Data included clinic blood pressure (BP), longitudinal ambulatory blood pressure monitoring (ABPM), echocardiography, serum creatinine, and first-morning urine protein/creatinine ratios. For patients with multiple ABPMs, results of initial and most recent ABPMs were compared. Results Of 422 patients followed in the multidisciplinary cancer survivorship clinic, 130 were seen by nephrology. Median time after therapy completion to first nephrology visit was 8 years. The most common diagnoses were leukemia/myelodysplastic syndrome (27%), neuroblastoma (24%), and Wilms tumor (15%). At last follow-up, 68% had impaired kidney function, 38% had a clinical diagnosis of hypertension, and 12% had proteinuria. There were 91 ABPMs performed in 55 (42%) patients. Patients with multiple ABPMs (n=21) had statistically significant reductions in overall median BP loads: systolic initial load 37% vs. most recent 10% (p=0.005) and diastolic load 36% vs. 14% (p=0.017). Patients with impaired kidney function were more likely to have received ifosfamide. Patients with hypertension were more likely to have received total body irradiation or allogeneic stem cell transplant. Conclusions History of leukemia/myelodysplastic syndrome, neuroblastoma, and Wilms tumor were frequent among survivors seen by nephrology. There was significant improvement in cardiovascular measures with increased recognition of hypertension and subsequent treatment.
Article
Therapeutic advancements have improved pediatric cancer prognosis, shifting the interest towards the management of psychosocial burden and treatment-related morbidity. To critically appraise the available evidence, we conducted an umbrella review of meta-analyses of randomized controlled trials on supportive interventions for childhood cancer. Thirty-four publications (92 meta-analyses, 1 network, 14,521 participants) were included. The most concrete data showed a reduction in procedure-related pain and distress through hypnosis. Moreover, exercise improved the functional mobility of the patients. Regarding pharmacological interventions, most of the meta-analyses regarded the treatment of nausea/vomiting (ondansetron was effective) and infections/febrile neutropenia [granulocyte-(macrophage) colony-stimulating factors showed benefits]. Substantial heterogeneity was detected in 31 associations. Conclusively, supportive interventions for pediatric cancer are being thoroughly evaluated. However, most of the studies are small and of moderate quality, highlighting the need for more randomized evidence in order to increase precision in improving the quality of life of patients, survivors and their families.
Article
Efficiency in healthcare is crucial since available resources are scarce, and the opportunity cost of an inefficient allocation is measured in health outcomes foregone. This is particularly relevant for cancer. The aim of this paper was to gain a comprehensive overview of how efficiency in cancer care is defined, and what the indicators, different methods, perspectives, and areas of evaluation are, to provide recommendations on the areas and dimensions where efficiency can be improved. Methods A comprehensive scoping literature review was performed searching four databases. Studies published between 2000-2021 were included if they described experiences and cases of efficiency in cancer care or methods to evaluate efficiency. The results of the literature review were then discussed during two rounds of online consultation with a panel of 15 external experts invited to provide their insights and comments to deliberate policy recommendations. Results 46 papers met the inclusion criteria. Based on the papers retrieved we have identified six areas for achieving efficiency gains throughout the entire care pathway and, for each area of efficiency, we have categorized the methods and outcome used to measure efficiency gain Conclusion This is the first attempt to systematize a scattered body of literature on how to improve efficiency in cancer care and identify key areas to improve it. Based on the findings of the literature review and on the opinion of the experts involved in the consultation, we propose seven recommendations that are intended to improve efficiency in cancer care throughout the care pathway.
Article
Prematurity is a common risk factor in children, affecting approximately 10% of live births, globally. It is more common in children with critical congenital heart disease (CCHD) and carries important implications in this group of patients. While outcomes have been improving over the years, even late preterm birth is associated with worse outcomes in children born with critical congenital heart disease compared to those without. Infants with both prematurity and CCHD are at particularly high risk for important comorbidities, including: necrotizing enterocolitis, intraventricular hemorrhage, white matter injury, neurodevelopmental anomalies and retinopathy of prematurity. Lesion-specific intensive care management of these infants, interventional and peri-operative management specifically tailored to their needs, and multidisciplinary care all have the potential to improve outcomes in this challenging group.
Article
Background Neuroblastoma is the most common extracranial solid tumor in children. Those with high-risk disease are treated with multimodal therapy, including high-dose chemotherapy, stem cell transplant, radiation, and immunotherapy that have led to multiple long-term complications in survivors. In the late 1990s, consolidation therapy involved myeloablative conditioning including total body irradiation (TBI) with autologous stem cell rescue. Recognizing the significant long-term toxicities of exposure to TBI, more contemporary treatment protocols have removed this from conditioning regimens. This study examines an expanded cohort of 48 high-risk neuroblastoma patients to identify differences in the late effect profiles for those treated with TBI and those treated without TBI. Procedure Data on the study cohort were collected from clinic charts, provider documentation in the electronic medical record of visits to survivorship clinic, including all subspecialists, and ancillary reports of laboratory and diagnostic tests done as part of risk-based screening at each visit. Results All 48 survivors of BMT for high-risk neuroblastoma had numerous late effects of therapy, with 73% having between five and 10 late effects. TBI impacted some late effects significantly, including growth hormone deficiency (GHD), bone outcomes, and cataracts. Conclusion Although high-risk neuroblastoma survivors treated with TBI have significant late effects, those treated without TBI also continue to have significant morbidity related to high-dose chemotherapy and local radiation. A multidisciplinary care team assists in providing comprehensive care to those survivors who are at highest risk for significant late effects.
Article
Objectives To provide a summary of the emerging and ongoing survivorship challenges facing childhood, adolescent, and young adult cancer survivors and their families. Data Sources Research and review articles, websites, and clinical guidelines specific to childhood cancer survivorship were used. Conclusion Many challenges exist in assuring quality long-term follow-up and risk-based screening for childhood cancer survivors. Although many childhood cancer survivors survive well into adulthood, they are at risk for a vast number of later complications of their cancer treatment necessitating annual cancer surveillance. In addition, many childhood cancer survivors are not engaging in long-term follow-up recommendations for clinic attendance, risk-based surveillance, and screening for potentially life-ending events. Pediatric oncology nurses and advanced practice nurses have played an enormous role in the design of childhood cancer survivorship programs and are an integral member of the multidisciplinary health care team who care for this population. Nurses have an obligation to continue to advance the survivorship care of childhood cancer survivors and lead interventional opportunities to improve the lifelong health-related quality of life and overall physical health. Implications for Nursing Practice Pediatric oncology nurses and advanced practice registered nurses must have a working knowledge of the many late effects that childhood cancer treatment has on the long-term health of childhood cancer survivors. Nurses are well-placed in positions to continue the efforts begun more than 2 decades prior by pediatric oncology nurses who saw the value and necessity of designated survivorship programs.
Article
As we move into the 21 st century, we are faced with an increasing number of childhood cancer survivors who are living into their middle adult years and beyond. Providing appropriate, comprehensive follow-up care is a challenge for health care providers and one that can be met by developing quality follow-up programs for all childhood cancer survivors. The focus of these programs should be to educate these survivors on strategies to maximize their health and well being. This article discusses the evolution of survivor clinics, strategies for developing a quality program, and the role of nursing in the care of childhood cancer survivors.
Article
An abstract is unavailable. This article is available as HTML full text and PDF.
Article
The evolution of the role of the pediatric nurse practitioner in oncology specializing in the care of childhood cancer survivors is described, with certain aspects of the role solidified or expanded and new functions added. The early concept of the role included three interdependent functions: (a) clinician /caregiver, (b) educator, and (c) researcher. The functions of specialty care provider and educator remain strong; the role of researcher has been expanded, and new role components, clinical/ program manager and consultant, have been added. The central focus for the pediatric nurse practitioner in oncology is the survivor and family, which is extended to the clinic population and related groups by the blending of the pediatric nurse practitioner and clinical nurse specialist roles. Any role function on behalf of this clinical population should be assumed as necessary to provide comprehensive care.
Article
The number of survivors of childhood cancer is steadily increasing as the long-term prognosis for cancer in children improves. As these patients reach adulthood, the need for continued follow-up related to the late effects of their cancer therapy is necessary. Such effects can occur in many body systems, although the cardiac effects of anthracyclines (doxorubicin and daunomycin Astra, USA Inc, West Borough, MA) are the most life threatening. It is important that survivors are educated about the treatments they received and that they and their health care providers are alert to the potential late effects.
Article
As we move into the 21st century, we are faced with an increasing number of childhood cancer survivors who are living into their middle adult years and beyond. Providing appropriate, comprehensive follow-up care is a challenge for health care providers and one that can be met by developing quality follow-up programs for all childhood cancer survivors. The focus of these programs should be to educate these survivors on strategies to maximize their health and well being. This article discusses the evolution of survivor clinics, strategies for developing a quality program, and the role of nursing in the care of childhood cancer survivors.